Brief: Guardion Health Sciences Reports Quarterly Loss Per Share Of $0.03
11/08/2022 15:26
Aug 11 (Reuters) - Guardion Health Sciences Inc GHSI.O :
* QUARTERLY REVENUE ROSE 37.3 PERCENT TO $3.275 MILLION
SEQUENTIALLY (ADDS DROPPED WORD 'SEQUENTIALLY')
* GUARDION HEALTH SCIENCES ANNOUNCES FINANCIAL RESULTS FOR
THE
QUARTER ENDED JUNE 30, 2022
* QUARTERLY LOSS PER SHARE $0.03
* AS OF JUNE 30, 2022, CO HAD CASH AND SHORT-TERM
INVESTMENTS OF
$14.2 MILLION AND WORKING CAPITAL OF $17.4 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nGNX2HYgHw
Further company coverage: GHSI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Guardion Health Sciences
See all newsBrief: Guardion Health Sciences Announces Termination Of CEO, Effective October 17
Brief: Guardion Health Sciences Announces Completion Of Sale Of Its Viactiv® Brand And Business To Doctor’S Best Inc. And Stockholder Approval Of Plan Of Liquidation And Dissolution
Brief: Guardion Health Sciences Announces Its Largest Stockholder Has Voted In Favor Of Proposals To Sell The Viactiv Business
Guardion Health Sciences Inc reports results for the quarter ended in March - Earnings Summary
Guardion Health Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview